NEW YORK (
CHANGE IN RATINGS
downgraded to hold at TheStreet Ratings.
upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $23 price target. Accretive acquisitions should help boost earnings.
downgraded to sell at TheStreet Ratings.
(BA - Get Report)
upgraded at Bernstein to Outperform. $92 price target. Demand outlook remains strong, despite macro risks.
(CG - Get Report)
rated new Neutral at Goldman. Valuation call, based on a $22 price target.
Carlyle rated new Overweight at JP Morgan. $26 price target. Company is a market leader that generates stable earnings growth.
Carlyle Group rated new Buy at UBS. $25 price target. Premier alternative manager poised to benefit from growing demand.
Carlyle Group rated new Buy at Citigroup. $29 price target. Model built for consistent distributions.
downgraded at Cantor from Buy to Hold. $29 price target. Estimates also cut, given higher costs in new markets.
upgraded at Argus from Hold to Buy, Argus Research said. $40 price target. Company is realizing higher crack spreads.
rated new Overweight at Morgan Stanley. URI was initiated with an Overweight rating, Morgan Stanley said. $46 price target. Company is leveraged to an eventual cyclical recovery.
STOCK COMMENTS / EPS CHANGES
(BEN - Get Report)
numbers reduced at BMO. Shares of BEN now seen reaching $126, according to BMO Capital. Estimates also cut, given lower asset flows. Market Perform rating.
estimates, target reduced at Morgan Stanley. Shares of FNSR now seen reaching $19, according to Morgan Stanley. Estimates also cut, as the company is losing market share and seeing lower prices in telecom. Overweight rating.
estimates, target reduced at BMO. IVZ estimates were cut through 2013, BMO Capital said. Company is hurt by lower market performance and currency headwinds. Outperform rating and new $27 price target.
(QCOM - Get Report)
estimates cut at BMO through 2012, BMO Capital said. Company is leveraged to lower unit sales at RIMM and HTC. Outperform rating and $77 price target.
numbers lowered at Citigroup. Shares of SAVE now seen reaching $27, Citigroup said. Estimates also lowered on slightly lower long term earnings growth rate. Buy rating.